4//SEC Filing
Lamadrid David 4
Accession 0001144204-11-052179
CIK 0001175151other
Filed
Sep 8, 8:00 PM ET
Accepted
Sep 9, 4:43 PM ET
Size
7.9 KB
Accession
0001144204-11-052179
Insider Transaction Report
Form 4
Lamadrid David
Chief Financial Officer
Transactions
- Exercise/Conversion
Stock Option
2011-09-06−12,500→ 7,837,500 totalExercise: $0.04From: 2011-09-06→ Common Stock (12,500 underlying) - Sale
Common Stock
2011-09-06$0.21/sh−12,500$2,688→ 7,837,500 total
Footnotes (3)
- [F1]The shares of common stock were sold by Mr. Lamadrid pursuant to a 10b5-1 trading plan, adopted by the reporting person on June 8, 2011.
- [F2]In addition to the currently outstanding shares of common stock owned by Mr. Lamadrid and reported here, Mr. Lamadrid also beneficially owns the shares of common stock underlying the following stock options: options to purchase 150,000 shares of common stock at $1.90 per share; options to purchase 1,400,000 shares of common stock at $0.25 per share; options to purchase 400,000 shares of common stock at $0.173 per share; options to purchase 400,000 shares of common stock at $0.168 per share, options to purchase 2,750,000 shares of common stock at $0.138 per share; and options to purchase 2,737,500 shares of common stock at $0.035 per share.
- [F3]N/A
Documents
Issuer
Cytosorbents Corp
CIK 0001175151
Entity typeother
Related Parties
1- filerCIK 0001368153
Filing Metadata
- Form type
- 4
- Filed
- Sep 8, 8:00 PM ET
- Accepted
- Sep 9, 4:43 PM ET
- Size
- 7.9 KB